The Selective Endothelin Receptor Antagonist SC0062 in IgA Nephropathy: A Randomized Double-Blind Placebo-Controlled Clinical Trial

J Am Soc Nephrol. 2024 Oct 26. doi: 10.1681/ASN.0000000538. Online ahead of print.
No abstract available

Associated data

  • ClinicalTrials.gov/NCT05687890

Grants and funding